focus -WSS

focus

author：leisure time 2025-10-01 19:59:24 Page View：8

Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.

To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Ransomware attacks on hospitals: Study outlines patient impact
Next article： Moonlake's readout produced a cash windfall. Risks remain

Wikipedia

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Medicare slashes safety net hospital payments by nearly $1 billion

Thefederalgovernmentwillpayhospitalsthattreatpooranduninsuredpatientsalmost$1billionlessnextyear.Ado

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

AdobePHILADELPHIA—NovoNordisk,whichhasdominatedthediabetesandobesitymarketswithitsblockbusterdrugsOz

focus

knowledge

Wikipedia

Buoyed by wins on obesity, Novo Nordisk eyes heart disease